Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_assertion description "[The absence of TLR2, MyD88, and MyD88xTrif conferred both physiologic and histologic protection against sublethal ischemia at 24 h. Interestingly, TLR2-deficient mice were better protected from ischemic renal injury than those deficient for the adapter protein MyD88, raising the intriguing possibility that TLR-2-dependent/MyD88-independent pathways also contribute to kidney injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_assertion evidence source_evidence_literature NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_assertion SIO_000772 17475853 NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_assertion wasDerivedFrom befree-20140225 NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_assertion wasGeneratedBy ECO_0000203 NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP709797.RAJPZE6OSVRnwSMabOkQ-I-ySIdyRKNNlVu-dKPjQOcSc130_provenance.